Professor Moore says the risk factors for cirrhosis often emerge in our 20s and it generally takes 20 years to develop, ‘so ...
The nitric oxide-independent soluble guanylate cyclase activator ataciguat continued to show promise for slowing the ...
Abdominal aortic aneurysm (AAA) is a severe aortic disease for which no pharmacological interventions have yet been developed. This investigation focused on identifying protein‐based therapeutic ...
The phase II data are promising for patients who are managed with watchful waiting before being offered an intervention.
If you need assistance, call the newsroom at 203-784-8801.